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ABSTRACT Cyanogen bromide-cleaved epidermal growth factor (CNBr-EGF) binds to EGF
receptors with reduced affinity compared to the native hormone but fails to induce DNA
synthesis . However, at similar receptor occupancy, CNBr-EGF is as potent as EGF in activating
early cell responses to the hormone . The phosphorylation of membrane proteins, the stimula-
tion of Na'-K+-ATPase as reflected by the ouabain-sensitive uptake of $6 Rb of fibroblasts,
changes in the organization of microfilaments and in cell-morphology, and the activation of
the enzyme ornithine-decarboxylase are all induced by CNBr-EGF as well as EGF.
Our results are consistent with the notion that EGF-induced phosphorylation could act as a
"second messenger" for the activation of various EGF-induced responses such as activation of
Na'-K+-ATPase, changes in the cytoskeleton and cell morphology, and the activation of the
enzyme ornithine decarboxylase . However, the stimulation of phosphorylation of membrane
proteins and other early responses are either not required or necessary but insufficient for the
induction of DNA synthesis .
Suboptimal concentrations of EGF together with CNBr-EGF stimulate DNA synthesis in
human fibroblasts . Other growth factors such as insulin, fibroblast growth factor, and prosta-
glandin F2a, which potentiate the mitogenic response of EGF, do not effect the response to
CNBr-EGF . This suggests that the restoration of the mitogenic properties of CNBr-EGF by
suboptimal doses of EGF occurs at the level of EGF receptors or during their processing .
Epidermal growth factor (EGF), a single chain polypeptide
hormone isolated from the mouse submaxillary gland (28), is
a potent mitogen for various epidermal and epithelial cells
both in vivo and in vitro (7) . The initial interaction of EGF
with target cells occurs at specific receptors which are homo-
geneously distributed over the cell surface. Subsequent to
binding, the mobile (31) hormone-receptor complexes rapidly
aggregate into clusters and collect over coated regions of the
plasma membrane (12, 13, 15, 23, 31, 32) . The EGF-receptor
complexes are then endocytosed by an energy-dependent proc-
ess and eventually degraded in lysosomes (12, 15) . At the same
time, EGF induces an array of metabolic alterations in cells .
These include early effects such as stimulation of nutrient
uptake (7, 14) and ion fluxes (26), enhanced phosphorylation
of endogenous membrane proteins (5, 6, 19), changes in cell
morphology (8), and cytoskeletal organization (34). Delayed
effects ofEGF include the activation of cytoplasmic enzymes
and the stimulation of protein and DNA synthesis (7) . The
question remains open of when and how EGF generates bio-
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chemical signals during the topographical rearrangement and
processing of hormone-receptor complexes . Furthermore, it is
not clear yet whether all EGF-induced effects are related to
each other by a single mediator and whether the observed
hormone responses converge into a common pathway leading
to DNA synthesis .
The importance of EGF-receptor aggregation for the induc-
tion of the EGF mitogenic response is indicated by the use of
an EGF derivative, obtained by cyanogen bromide cleavage
(CNBr) of the hormone (37) . Cyanogen bromide-cleaved EGF
(CNBr-EGF) binds with reduced affinity to EGF receptors but
fails to induce receptor clustering or DNA synthesis . The cross-
linking of this derivative with bivalent anti-EGF antibodies
restores both cluster formation and stimulation of DNA syn-
thesis (33, 37) .
In this report we characterize the biological activity ofCNBr-
EGF on cultured cells . Surprisingly, at equal receptor occu-
pancy, the nonmitogenic CNBr-EGF appears to behave as a
full agonist ofEGF in all the biological assays studied except
687DNA synthesis . Our results present CNBr-EGF as a versatile
tool for investigating the mode of action of EGF and are
discussed in the light of a possible mechanistic uncoupling of
EGF early and delayed responses .
MATERIALS AND METHODS
Materials
EGF was purified from the submaxillary glands of adult male mice by the
method of Savage and Cohen (28) . 125I-EGFwas prepared by the chloramine T
method (17) to a specific activity of 80,000-120,000 cpm/ng . CNBr-EGF was
prepared as reported and characterized by amino acid analysis (36, 37) .
"Rubidium chloride ("RbCl) and L-[l-'"C]ornithine (54.1 mCi/mmol) were
obtained from New England Nuclear (Boston, MA). iy-'2P]-ATP (16 Ci/mmol)
and ['H-methyl]thymidine (47 Ci/mmol) were purchased from the Radiochemical
Centre, Amersham Corp. (Arlington Heights, IL) . 7-Nitrobenz-2-oxa-l,3-diazole
phallacidin (NBD-phallacidin) was a generous gift from Dr. L. Barak . Ouabain
and porcine insulin were purchased from Sigma Chemical Co . (St . Louis, MO).
Prostaglandin F2m (PGFza) was a gift from Dr. J . Pike (Upjohn College). Bovine
pituitary fibroblast growth factor (FGF) was a kind gift from Dr. I . Vlodavsky .
Cells
Human epidermoid carcinoma cells (A-431 cell line) were kindly provided by
Dr. G . Todaro . Human foreskin fibroblasts (HFF) from primary cultures were
a gift from Drs . D . Rothman andM. Gabbay. Swissmouse 3T3 fibroblasts were
obtained from Dr . A . Ben-Zeev. All cells were grown in Dulbecco's modified
Eagle's medium (DMEM) containing 10% heat-inactivated fetal calf serum
(FCS).
Binding Studies
Binding of 'Z SI-EGF was performed on confluent monolayers ofliving cells in
24 well Costar trays (Costar, Data Packaging, Cambridge, MA) as described
elsewhere (43) .
Microscopy
Cells were plated at low density in 35-mm plastic culture dishes. I and 2 h
after the addition ofeither 50 ng/mlEGF or 500 ng/ml CNBr-EGF, in DMEM
containing 0.1% bovine serum albumin (BSA), the cells were observed with a
Zeiss inverted microscope IM 35 . For fluorescent labeling of actin, cells were
fixed with 3% paraformaldehyde and treated with 0.1% Triton X-100 at room
temperature . Permeabilized cells were then incubated with 2ng/ml NBD-phal-
lacidin for 20 min . Photographs were taken on Kodak Tri-X film .
Membrane Phosphorylation Reaction
A membrane preparation of A-431 cells was obtained by the procedure of
Thom et al . (39) . Phosphorylation reactions were conducted as reported previ-
ously (5, 6, 19, 35) . Briefly, 30 jig ofmembrane protein were preincubated at 0°C
for 15 min with increasing concentrations of either EGF or CNBr-EGF in 20
mM HEPES buffer (pH 7.4) containing 50mM MgCl and0.01% BSA in a final
volume of 50 Id before addition of [y-"P]-ATP (50 nM) for 10 min at 0°C.
Aliquots were pipettedonWhatmanNo . 3 filterpapers (Whatman, Inc.,Chemical
Separation Div ., Clifton, N. J.) which were immediately dropped into cold 10%
trichloroacetic acid (TCA)-0.1 M pyrophosphate, extensively washed with this
solution, and extracted with ethanol and ether. The radioactivity of the filters
was then counted in a liquid scintillation counter.
86Rb + Uptake Measurements
HFF were grown to confluence in 35-mm dishes (Nunc, Kampstrup, Den-
mark) and starved in serum-free medium two days before the assay . After 10 min
of preincubation at 37°C with either EGFor CNBr-EGF, cells were incubated
at 37°C for 10 min with 0.5 ltCi of"RbCl in a final volume of2501x1. Cells were
then rapidly washed with 10 ml ofice-cold phosphate-buffered saline, and 0.5 ml
ofice-cold 5%TCAwas added to each well . The TCA-soluble radioactivity was
determined directly in a liquid scintillation counter. Control systems were incu-
bated for 1 min with 1 mM ouabain before the addition of "RbCl . Zero time
uptake was measured and subtracted from the average of triplicates.
Induction of Ornithine Decarboxylase Activity
Mouse fibroblasts (Swiss 3T3) were grown to confluence in 35-mm dishes and
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then maintained for 2d in medium containing 0.5%FCS before the assay .EGF
or CNBr-EGF were added to the cells for various times at 37°C . Cells were
washed with ice-cold buffer solutionA(50mM Tris-HCI, 1mM EDTA,pH 7.4),
collected with a rubber policeman in 0.2 ml of buffer solution Aand frozen and
thawed three times. After centrifugation (10 min at 4°C, 12,000 g), ornithine
decarboxylase activity was determined by incubating 180 lxl of the supernatant
solution with 20 pl of assay buffer (0.5 mM pyridoxalphosphate, 12 .5 mM
dithiothreitol, and 0.2 pCi [1- r"C]ornithine in buffer solution A) . The reaction
was conducted in plastic tubes covered with a rubber stopper supporting a
polyethylene center well (KontesCo., Vineland, NJ) filled with Whatman No . 3
filter paper soaked in NCS Tissue Solubilizer (Amersham/Searle Corp., Ill.).
After incubation at 37°C for 1 h, 05 ml of 50% TCA wasadded and incubation
at 37°C was allowed to proceed for 30 min . Center wells were then removed and
their radioactive content was determined .
Stimulation of Thymidine Incorporation
Cells for assay weregrown to confluence in 24 well Costar trays (Costar, Data
Packaging) and then maintained for 2 d in medium containing 0.5% FCS.
Hormones were added to the cells 18 h before a 4-h pulse of ['H-methyl]-
thymidine (0.5 pCi) . Cells were washed three times with phosphate-buffered
saline, and the TCA nonextractable radioactivity was determined in a liquid
scintillation counter.
RESULTS
EGF has a single methionyl residue at position 21 (7), and
cleavage with cyanogen bromide results in the formation of
two polypeptide chains connected by the three disulfide bonds
of the protein molecule. Amino acid analysis of an acid hy-
drolysate ofCNBr-EGF revealed the full conversion ofmethi-
onine into homoserine lactone . CNBr-EGF was shown to have
a tertiary structure similar to that ofEGF, but it is less stable
than the native hormone to denaturation by 4M ofguanidinum
chloride (16) . However, CNBr-EGF is a stable protein and
intact EGF is a very stable protein (16) . CNBr-EGF binds to
EGF-receptors on A-431 cells and membranes prepared from
these cells and also to EGF receptors on HFF and 3T3 fibro-
blasts with an affinity 1/10 that ofEGF (36, 37) (Table 1) and
fails to induce visible clustering ofEGF receptors (33, 37). The
nonmitogenic activity of CNBr-EGF is not related to its re-
duced stability, since either anti-EGF antibodies (37) or sub-
optimal concentration of native EGF restore its full mitogenic
activity .
TABLE I
Comparison of Binding and Biological Properties of EGFand
CNBr-EGF
* Similar results for50% displacement of [" sl]EGF were obtained for HFF and
3T3 cells .
$Maximal stimulation of DNA synthesis (1,000%-2,000% above control) in
3T3 and HFF cells is achieved at 10 ng/ml EGF. CNBr-EGF does not stimulate




50% Displacement of 10 ng/ml [' 251]EGF 10 100
binding to A-431 cells*
Stimulation of ouabain-sensitive 86Rb influx 20 150
(200% above control) in HFF
Enhancement of endogenous membrane 150 1,200
protein phosphorylation (250%abovecon-
trol) (A-431 membrane preparation)
Induction of ornithine decarboxylase in 3T3 10 100
cells (350% above control)
Induction of morphological changes in A- 50 500
431 cells
Reorganization of the microfilament system 50 500
in A-431 cells
Stimulation of DNAsynthesis in 3T3 and HFF 10 -
ceIIsfFIGURE 1
￿
Morphological changes induced by EGF or CNBr-EGF in A-431 cells . Phase-contrast micrographs of A-431 cells grown
to sparse density in 35-mm plastic dishes and incubated for 1 h at 37°C with medium (A, B, and C), 50 ng/ml EGF (D, E, and F),
and 500 ng/ml CNBr-EGF (G, H, and 1) . A-431 cells appear as flat, closely associated cells (B and C) with a smooth plasma
membrane (A) . In the presence of either EGF or CNBr-EGF, the cells round up and pile up to form multilayered colonies (E-G)
while exhibiting membrane activity (see arrows in D and G) . x 732 .
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689EGF mediates physiological responses in target cells which
occur at different times after the addition of the hormone . We
undertook a comparison ofthe effects ofEGF and CNBr-EGF
on these responses .
Membrane Phosphorylation
EGF rapidly activates a cyclic mucleotide independent pro-
tein kinase specific for tyrosine residues (41). This protein
kinase has been copurified with the EGF membrane receptor
(9). Addition of EGF and [y-32P]ATP to a membrane prepa-
ration from A-431 cells enhances the phosphorylation of en-
dogenous membrane proteins . Addition ofCNBr-EGF yields
the same effect (Table I), at a concentration of the derivative
about tenfold that of the native hormone . It has been shown
previously (36) that EGF and CNBr-EGF stimulate the phos-
phorylation of the same membrane components .
86Rb Uptake
EGF stimulates transiently the Na'-K+-ATPase of target
cells shortly after binding to cellmembrane receptors (26). The
effect of EGF and CNBr-EGF on ouabain-sensitive 86Rb+
uptake which reflects the activity of Na'-K+-ATPase was
studied in HFF . As can be seen from Table I, both EGF and
CNBr-EGF enhanced the ouabain-sensitive 'Rb+ influx about
twofold over basal activity, provided the same receptor
occupancy is reached. Basal influx was 1,230 ± 300cpm;EGF
(10 ng/ml) induced influx of 2,160 ± 360 cpm, and CNBr-
EGF (100 ng/ml) induced influx of2,120 ± 200cpm into HFF
cells . Similar effects of EGF and CNBr-EGF on 'Rb influx
were observed on A-431 cells but measurements on these cells
were less accurate due to nonselective pinocytosis induced by
the hormones (14) .
FIGURE 2
￿
Reorganization of actin filaments induced by EGF or CNBr-EGF in A-431 cells . A-431 cells growing on glass covet slips
were incubated for 1 h at 37°C with medium (A), 50 ng/ml EGF (8), and 500 ng/ml CNBr-EGF (C) . The cells were fixed with 0.1%
formaldehyde, permeabilized with 0.1% Triton X-100, and labeled with 2 ng/ml of NBD-phallacidin, a fluorescently labeled
mushroom toxin which specifically labels F-actin inside the cells . The fluorescence micrographs show the well-organized pattern
of the actin-containing microfilament system in untreated (A) A-431 cells . Both EGF (8) and CNBr-EGF (C) induce the
reorganization of the F-actin-containing filaments in these cells. x 732.
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Morphological and Cytoskeletal Changes
EGF transiently alters the morphology (8) and the cytoskel-
etal organization (34) of A-431 cells . Similar effects can be
observed on other EGF-sensitive cell types but they are most
striking on A-431 cells which bear an unusually high number
ofEGF receptors (11, 42) . A-431 cells grow in culture as flat,
closely associated cells (Fig. 1 A-C) . After incubation at 37°C
for 2 h with either 50 ng/ml EGF (Fig . 1 D-E) or 500 ng/ml
CNBr-EGF (Fig. 1 G-H), the cells show extensive membrane
activity (see arrows in Fig. 1 D and G), round up (Fig. I E and
H), and form multilayered colonies (Fig. 1 F and I) . The
effects of EGF or CNBr-EGF on the organization of actin
filaments in A-431 cells are depicted in Fig . 2. Actin was
visualized after paraformaldehyde fixation and Triton X-100
permeabilization of the cells by labeling with NBD-phallacidin
(2) . In A-431 cells, actin is organized in fiber bundles which
often span the entire length of the cell and are oriented in
different directions;'some ofthe actin bundles appear in beltlike
structures (34) (Fig . 2 A). After incubation with either 50 ng/
mlEGF (Fig. 2 B) or 500 ng/ml CNBr-EGF (Fig . 2 C) at 37°C
for 1 h, most of the well-organized actin bundles are no longer
visible ; rather, an intense diffuse labeling is seen in the cyto-
plasm. The double-labeling experiment with NBD-phallacidin
and anti-actin antibodies indicated that the two reagents dec-
orate similar patterns (microfilaments) in cultured cells (40) .
For both EGF and CNBr-EGF, the morphological and micro-
filament alterations are transient; after more than 8 h of
incubation at 37°C, cells resumed their original morphology
and cytoskeletal organization (34) .
Induction of Ornithine Decarboxylase
The increase in activity of the cytoplasmic enzyme omithine
decarboxylase (ODC), which catalyzes the first step in thesynthesis of polyamines, is an important component of the
proliferative response of cells to a mitogenic stimulus. Maximal
stimulation ofODC activity in 3T3 fibroblasts is observed after
4 h ofincubation with EGF (Fig . 3) . CNBr-EGF appears to be
a full agonist ofEGF in the induction of this delayed effect of
EGF, provided a tenfold higher concentration ofCNBr-EGF
is used to compensate for its reduced affinity for EGF-receptors
(Figs . 3 and 4) .
DNA Synthesis
The mitogenic activity of EGF is measured in terms of the
stimulation ofthymidine incorporation into target cells induced
by the hormone. Maximal stimulation of thymidine incorpo-
ration occurs 16-18 h after binding of EGF . As previously
reported for 3T3 fibroblasts (37) and human fibroblasts (Fig.
5), CNBr-EGF is a hundredfold less potent than EGF in
inducing DNA synthesis. CNBr-EGF is also inactive in the in
vivo assay for EGF, namely precocious opening of eyelids of
newborn mice (16) .
As CNBr-EGF competes for binding of EGF to its mem-
brane receptors and behaves as an agonist of the EGF-medi-
ated short-term effects, we examined the possibility that it acts
as an antagonist ofEGF for the induction of DNA synthesis.
Surprisingly, low concentrations of EGF together with CNBr-
EGF clearly work synergistically on the enhancement of thy-
midine incorporation into HFF (Fig. 5) ; similar results were
obtained when EGF and CNBr-EGF were added to 3T3
fibroblasts (data not shown) . It should be noted that at all
concentrations ofEGF andCNBr-EGF incubated together the
FIGURE 3 Kinetics of the stimulation of ODC activity by EGF or
CNBr-EGF in mouse3T3 fibroblasts . 3T3 cells were grown to conflu-
ence in 35-mm plastic dishes and furthergrown in medium contain-
ing 0.5% fetal calf serum before the assay . Cells were incubated for
various periods of time with either 10 ng/ml EGF ("l100 ng/
ml CNBr-EGF ("-"), or buffer (0----0) . Measurement of ODC
activity was performed as described under Materials and Methods.







Concentration of hormone flog ng/ml)
FIGURE 4
￿
Stimulation of ODC activity by either EGF or CNBr-EGF
in mouse 3T3 fibroblasts . Cells were incubated with increasing
concentrations of either EGF (0-0) or CNBr-EGF ("-") . Mea-
surements of ODC activity aredescribed in Materials and Methods.
Results are the average of three measurements .
stimulation effect does not exceed the maximal effect ofEGF.
As synergistic effects between hormones are well documented
(18, 27), we investigated whether other hormones and growth-
factors which modulate the mitogenic effect of EGF would
also restore the potency ofCNBr-EGF for induction ofDNA
synthesis. Results for insulin, FGF, and PGF2 are shown in
Fig. 6 . Insulin and PGF2q alone are practically nonmitogenic
for HFF, whereas FGF at 50 ng/ml enhances thymidine
incorporation about twofold above control . All three hormones
W
0 25 50 75 100 25 50 75 100
Concentration of CNBrEGF (ng/ml) Concentration of EGF (ng/ml)
FIGURE 5 Induction of DNA synthesis in quiescent fibroblasts by
the addition of EGF together with CNBr-EGF. Enhancement of [3H-
methyl]thymidine incorporation in quiescent human foreskin fibro-
blasts incubated with increasing concentrations of CNBr-EGF alone
(A, 0-0), or together with 0.25 ng/ml EGF (A,*--*), 0.5 ng/ml
EGF (A, A-A), 1 ng/ml EGF ("-"), and 2 ng/ml EGF (V-0) : the
effect of induction with increasing concentrations of EGF alone
(Q-0) is shown in B. Cells were incubated at 37aC for 18 h with
the hormone(s) before a 4-h pulse with [3H-methyl]thymidine and







Concentration of insulin lng/ml)
0 500 1,000
Concentration of PGFa Ir-g/ml)
FIGURE 6 Synergistic effects of insulin, FGF, or PGF2 a with either
EGF or CNBr-EGF on the initiation of DNA synthesis in quiescent
fibroblasts . Enhancement of [
3 H-methyl]thymidine incorporation in
quiescent human foreskin fibroblasts incubated with increasing
concentrations of insulin (top), FGF (middle), and PGF2 a (bottom)
alone (0-A) or together with either 10 ng/ml CNBr-EGF (0--0) or
1 ng/ml EGF (0--" ) . Cells were incubated at 37aC for 18 h with the
hormone(s) before a 4-h pulse with [3H-methyl]thymidine and
determination of the trichloroacetic acid-nonextractable radioactiv-
ity .
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691act clearly in synergy withEGF but only in an additive fashion
withCNBr-EGF overthe entire concentration range examined .
DISCUSSION
EGF binding to cells initiates a series of changes in cell
metabolism which begins within minutes of hormone binding
but which persists for many hours afterward . The last change
in the series is an increase in DNA synthesis and ultimately
mitosis .
The binding of EGF to cell surface receptors is followed by
internalization of the hormone-receptor complexes. This raises
at least three different mechanisms for the transduction of its
biological activity.
(a) EGF acts at the level of the cell surface to generate
directly, or indirectly via a "second messenger" (e.g ., phospho-
rylation, or intracellular concentration ofions and metabolites),
a signal that triggers both rapid and delayed responses . Alter-
natively, one or more of the rapid responses may produce the
signal for the long-term effects . In this model, internalization
does not participate in the signaling process; it is instead related
to the desensitization of the cell to the growth factor .
(b) EGF generates a signal at the level of the plasma mem-
brane for the rapid responses, and the internalized hormone or
its fragments produce an independent signal by interaction
with putative intracellular sites for the long-term effects .
(c) EGF binding to the cell surface receptors creates the
appropriate perturbation in the receptor molecule which by
itself is the active species.
One approach to resolve between these possibilities is to use
drugs which inhibit specific stages in the processing ofEGF-
receptor complexes and to examine their effects on the biolog-
ical response mediated by the hormone (3, 20, 24, 29, 43) .
Another approach to resolve between these possibilities is to
establish analogues ofEGF which bind to EGF receptors and
then analyze their biological properties . We have recently
reported on the generation of monoclonal antibodies directed
against EGF-receptors (35) . These antibodies mimic both the
early and delayed responses mediated by EGF, suggesting that
the receptor rather than the hormone is the important moiety
for the transduction of the biological signal .
Here we show, using an EGF analogue CNBr-EGF, that
stimulation ofDNA synthesis need not occur even if the early
part of the series, including changes in metabolism up to 4 h
after hormone binding, does occur. It appears, then, that events
of activation of protein phosphorylation, ion transport, and
induction of enzyme activities either are not required, or else
are necessary but insufficient, to trigger DNA synthesis (21) .
Of course, this interpretation is based on the premise that
CNBr-EGF and native-EGF bind to the same class ofreceptors
which, when properly stimulated, initiate the full series of
metabolic changes leading to mitosis. The possibility that
CNBr-EGF binds to a subset of receptors, whose stimulation
triggers only part of the pathways to mitosis, is unlikely since
Scatchard analysis ofEGF binding to cells indicates the pres-
ence of only one class of binding sites (4) . Moreover, CNBr-
EGF blocks the binding of EGF to its receptors and hence
must bind to the same sites as the native hormone (35, 37) .
EGF-induced phosphorylation of membrane proteins does
not lead to activation of DNA synthesis. However, EGF- or
CNBr-EGF-induced phosphorylation could lead to the acti-
vation of Na'-K+-ATPase (26) and also to structural changes
in the cell's microfilament system . Such a mechanism has been
suggested for the src gene product, which in many aspects
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resembles the EGF-receptor-associated kinase and which has
been shown to affect the activity of Na'-K+-ATPase and the
organization of the cytoskeleton (1, 10, 22, 25, 30, 41) . Our
results make it unlikely that the initial portion of the cascade
ofprotein phosphorylation is a sufficient trigger for mitosis . If
the src gene product and EGF-receptor-associated kinase in-
deed operate via a common pathway (41), then other steps
must be required after or in parallel with protein phosphoryl-
ation to trigger DNA synthesis .
Although CNBr-EGF is not mitogenic by itself, suboptimal
amounts of EGF restore its mitogenic activity . A synergism
between hormones was reported for fibroblast growth factor
which induces DNA synthesis in 3T3 cells only in the presence
of insulin (27) . Synergistic effects between hormones are usu-
ally interpreted as the convergence of several pathways into a
common step initiating DNA synthesis, by increasing the prob-
ability for the cell to enter the S state of its cycle (38) . In the
case ofCNBr-EGF, only EGF possesses a synergistic potential
while insulin, PGF za and FGF are unable to restore the mito-
genic activity of the inactive CNBr-EGF . Apparently, the
critical event for DNA synthesis in which CNBr-EGF is defec-
tive seems to be related to EGF receptor and its processing . It
is noteworthy that cross-linking of the cell-bound CNBr-EGF
by anti-EGF-antibodies restores mitogenic activity and recep-
tor clustering, thus suggesting that receptor clustering plays a
role in the initiation ofDNA synthesis (33, 37) .
The separation ofearly and late EGF functions tells against
models ofEGF action in which early changes in cell metabo-
lism, for example, phosphorylation of membrane proteins,
provide internal stimuli for the late events ofDNA synthesis .
Hence our results favor a model ofEGF action which involves
several biochemical signals. These signals may arise during the
various stages of the processing of EGF-membrane receptor
complexes (clustering, internalization, and degradation) . Itmay
be that a combination ofstimuli from surface and internalized
hormone-receptor complexes leads to DNA synthesis . Such a
combination of stimuli would explain the synergistic effects on
DNA synthesis of native EGF and CNBr-EGF .
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